BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2004
View Archived Issues
New formulations comprising epinastine
Read More
Antibacterial ketolides claimed by Taisho
Read More
New compounds for neurological disorders described in a patent
Read More
Ono claims elastase inhibitors for COPD, pulmonary emphysema, rheumatoid arthritis, etc.
Read More
Researchers at Aponetics describe apoptosis-inducing agents
Read More
New HDAC inhibitors described by Roche
Read More
New antioxidants in early development at Japan Science and Technology
Read More
Camptothecin combinations for the treatment of tumors
Read More
MT-201 cleared to enter phase II U.S. trial in metastatic breast cancer
Read More
BioMarin and Suntory form strategic partnership for Phenoptin
Read More
Enrollment completed in phase II lipodystrophy study of EG-005
Read More
Pipeline progression at Antisoma
Read More
Gedeon Richter and Forest collaborate on atypical antipsychotic RGH-188
Read More
deCODE genetics and Roche establish PDE4 inhibitor collaboration
Read More
Confirmatory phase III study for Frova opens enrollment
Read More
SRP-299 discontinued for moderate to severe pediatric atopic dermatitis
Read More
Sirna-027 enters phase I study for wet AMD
Read More
Positive preliminary results from phase I/II study of PA-457
Read More
Specific Akt inhibitor shows antiproliferative and antiapoptotic effects
Read More
Novel orally available PDGFR inhibitors from Millennium
Read More
VEGFR vaccine blocks initiation and progression of atherosclerosis
Read More
Cytochroma cleared to begin Canadian phase Ia study of CTA-018 for psoriasis
Read More
Pivotal generalized anxiety disorder study under way for ocinaplon
Read More
Phase II NSCLC trial of KOS-862 discontinued
Read More
Tysabri approved for multiple sclerosis
Read More
Intravenous use of Remodulin approved for pulmonary arterial hypertension
Read More
Nicaraven cardioprotective in sepsis model
Read More
Update on the effects and safety of veglin in refractory cancer
Read More
Statins may decrease mortality in pneumonia patients
Read More
ChimeriVax-JE reported safe and immunogenic in healthy volunteers
Read More
Antitumor efficacy and safety of a panitumumab-based regimen in colorectal cancer
Read More
Isatoribine reduces HCV viral load in patients with chronic hepatitis C
Read More
Therapeutic benefits of the Enteryx(R) procedure in GERD
Read More